secwatch / observer
8-K filed November 19, 2021, 6:59 PM ET ticker MD CIK 0000893949
leadership confidence high sentiment neutral materiality 0.30

Mednax CFO Richards named PAO; Board adopts majority vote for directors; Moore promoted

Pediatrix Medical Group, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

John C. Pepia

Senior Vice President and Chief Accounting Officer
MD · Pediatrix Medical Group, Inc.
Effective
2021-11-16
Filed
November 19, 2021, 6:59 PM ET
Mr. John C. Pepia, who previously served as the Company’s Principal Accounting Officer, will continue to serve as the Company’s Senior Vice President and Chief Accounting Officer.
Role change

C. Marc Richards

Principal Accounting Officer
MD · Pediatrix Medical Group, Inc.
Effective
2021-11-16
Filed
November 19, 2021, 6:59 PM ET
On November 16, 2021, the Board of Directors (the “Board”) of Mednax, Inc., a Florida corporation (the “ Company ”), determined that Mr. C. Marc Richards, currently the Executive Vice President and Chief Financial Officer and Principal Financial Officer of the Company, would also serve as Company’s Principal Accounting Officer, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.7

John C. Pepia changed role as Senior Vice President and Chief Accounting Officer at Pediatrix Medical Group, Inc..

Role
Senior Vice President and Chief Accounting Officer
Exact text from the filing
Mr. John C. Pepia, who previously served as the Company’s Principal Accounting Officer, will continue to serve as the Company’s Senior Vice President and Chief Accounting Officer.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

C. Marc Richards changed role as Principal Accounting Officer at Pediatrix Medical Group, Inc..

Role
Principal Accounting Officer
Exact text from the filing
On November 16, 2021, the Board of Directors (the “Board”) of Mednax, Inc., a Florida corporation (the “ Company ”), determined that Mr. C. Marc Richards, currently the Executive Vice President and Chief Financial Officer and Principal Financial Officer of the Company, would also serve as Company’s Principal Accounting Officer, effective immediately.
View on SEC.gov

Pediatrix Medical Group, Inc. filing history →

Source: SEC EDGAR
accession 0000950170-21-004821
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.